(Nasdaq:HBIO), a life sciences tools company, says the first two successful stem cells laryngotracheal transplants have been completed in Russia, using the company’s specially designed bioreactor to grow the stem cells, which were taken from the patients’ bone marrow.
View the original article here: Harvard Bioscience stem cells in Russian tracheal transplants – The Business Journal
Share this article
